Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Cost of Revenue (2022 - 2025)

bioAffinity Technologies has reported Cost of Revenue over the past 4 years, most recently at $900126.0 for Q4 2025.

  • Quarterly Cost of Revenue fell 42.38% to $900126.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 million through Dec 2025, down 29.36% year-over-year, with the annual reading at $4.2 million for FY2025, 29.36% down from the prior year.
  • Cost of Revenue was $900126.0 for Q4 2025 at bioAffinity Technologies, down from $942211.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.7 million in Q4 2023 and troughed at $87.0 in Q1 2023.
  • The 4-year median for Cost of Revenue is $942211.0 (2025), against an average of $796775.0.
  • Year-over-year, Cost of Revenue surged 1808452.87% in 2024 and then crashed 42.38% in 2025.
  • A 4-year view of Cost of Revenue shows it stood at $175.0 in 2022, then surged by 951248.0% to $1.7 million in 2023, then decreased by 6.17% to $1.6 million in 2024, then crashed by 42.38% to $900126.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Cost of Revenue are $900126.0 (Q4 2025), $942211.0 (Q3 2025), and $1.0 million (Q2 2025).